Earnings History Data for InMed Pharmaceuticals Inc. (INM) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
InMed Pharmaceuticals Inc.
InMed Pharmaceuticals Inc. is a clinical-stage pharmaceutical company. It engages in developing a pipeline of cannabinoid-based medications, initially focused on the therapeutic benefits of cannabinol in diseases with unmet medical need. InMed Pharmaceuticals Inc. is based in VANCOUVER, BC.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 17-02-2023 | AH | INM | InMed Pharmaceuticals | 2.00 | -0.91 | -4.50 | 0.00 | InMed Pharmaceuticals GAAP EPS of -$0.91, revenue of $0.47M [2/17/2023 5:11 PM] |
1.60 | -0.03 (-1.84%) |
1.69 | 0.09 (5.62%) |
1.23 - 35.50 | 66,631 | 180,000 | 17,487 | ||
|
|
||||||||||||||||||
| 14-11-2022 | PM | INM | InMed Pharmaceuticals | 2.00 | -4.06 | -4.25 | 0.00 | InMed Pharmaceuticals GAAP EPS of -$4.06, revenue of $0.32M [11/14/2022 1:12 AM] |
2.80 | -0.20 (-6.67%) |
2.95 | -0.05 (-1.67%) |
2.40 - 59.25 | 59,490 | 60,000 | 2,711 | ||
|
||||||||||||||||||
| 23-09-2022 | PM | 7:30 AM ET (Sep 23) |
INM | InMed Pharmaceuticals Inc. | 10.52 | -12.92 | -5.50 | -10.25 | 5.53 | -1.39 (-20.12%) |
6.69 | -0.23 (-3.27%) |
5.12 - 59.25 | 233,979 | 4,040,000 | 6,264 | ||
| 14-02-2022 | PM | 7:30 AM ET (Feb 15) |
INM | InMed Pharmaceuticals Inc. | 16.68 | -0.31 | -0.23 | -0.37 | InMed Pharmaceuticals GAAP EPS of -$0.31, revenue of $0.27M [2/15/2022 3:06 AM] |
1.16 | 0.02 (1.75%) |
1.14 | 0.0 (0.00%) |
0.92 - 5.50 | 47,186 | 40,000 | 914 | |
|
||||||||||||||||||
| 10-11-2021 | PM | 7:30 AM ET (Nov 10) |
INM | InMed Pharmaceuticals | 13.00 | -0.25 | -0.35 | 0.00 | InMed Pharmaceuticals reports FQ1 results [11/10/2021 9:03 AM] |
1.33 | -0.07 (-4.82%) |
0.0 | 0.0 (0.00%) |
1.30 - 6.42 | 399,500 | 340,000 | 0 | |
| 24-09-2021 | PM | 7:30 AM ET (Sep 24) |
INM | InMed Pharmaceuticals Inc. | 16.45 | -0.41 | -0.34 | 0.00 | 1.82 | -0.01 (-0.55%) |
1.90 | 0.07 (3.83%) |
1.76 - 8.94 | 155,331 | 240,000 | 19,417 | ||
| 13-05-2021 | PM | (May 13) |
INM | InMed Pharmaceuticals Inc. | 28.34 | -0.41 | -0.24 | 0.00 | InMed Pharmaceuticals reports FQ3 results [5/13/2021 7:34 AM] |
2.81 | -0.57 (-16.86%) |
0.0 | 0.0 (0.00%) |
2.65 - 10.43 | 130,787 | 60,000 | 0 | |
| 11-02-2021 | PM | INM | InMed Pharmaceuticals Inc. | 31.50 | -0.37 | -0.24 | 0.00 | InMed Pharmaceuticals reports Q4 results [2/11/2021 7:42 AM] |
5.19 | 0.15 (2.98%) |
5.25 | 0.21 (4.17%) |
2.95 - 10.43 | 359,949 | 693,288 | 26,755 | ||